ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BHVN vs ZLAB // EV/EBITDA & P/E VALUATION

Biohaven Ltd. (NYSE) VS. Zai Lab Limited (NASDAQ) • 15-METRIC TALLY: BHVN 1 — ZLAB 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHVN VS. ZLAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BHVN ZLAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 58.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -24.50% -6.33% -18.17 ZLAB /fcf-yield <GO>
Operating Margin — -50.20% — TIE /operating-margins <GO>
Net Profit Margin — -38.40% — TIE /net-margins <GO>
Revenue Growth (YoY) — 15.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 ZLAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.1 40.3 +20.77 BHVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.49B $2.51B -$19.6M ZLAB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BHVN REV ZLAB REV BHVN GROSS % ZLAB GROSS % BHVN FCF ZLAB FCF
FY 2025 $0 $457.2M — 58.3% -$610.2M -$158.9M
FY 2024 $0 $397.6M — 63.0% -$586.5M -$220.5M
FY 2023 $0 $266.7M — — -$331.7M -$198.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHVN // BETA —
ZLAB // BETA —